A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential (Q27824814)

PubMed

PubMed publication ID

15146165

13 November 2016

title

A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential (English)

1 reference

PubMed

PubMed publication ID

15146165

Agnieszka Dansonka-Mieszkowska

13 November 2016

author

2

Agnieszka Dansonka-Mieszkowska

0 references

L. H. Sobin

3

Leslie H Sobin

0 references

Markku Miettinen

4

Markku Miettinen

0 references

Jerzy Lasota

1

Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors

Jerzy Lasota

0 references

publication date

July 2004

0 references

published in

Laboratory Investigation

0 references

volume

84

0 references

issue

7

0 references

page(s)

874-83

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Familial gastrointestinal stromal tumours with germline mutation of the KIT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Pleomorphic characteristics of a germ-line KIT mutation in a large kindred with gastrointestinal stromal tumors, hyperpigmentation, and dysphagia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

PDGFRA activating mutations in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Regulation and targets of receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Tyrosine kinases as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Imatinib inhibits various types of activating mutant kit found in gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Clinical management of gastrointestinal stromal tumors: before and after STI-571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

c-kit gene mutation at exon 17 or 13 is very rare in sporadic gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Activating c-kit gene mutations in human germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of interstitial cells of Cajal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

Cause of familial and multiple gastrointestinal autonomic nerve tumors with hyperplasia of interstitial cells of Cajal is germline mutation of the c-kit gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

7 January 2021

Familial gastrointestinal stromal tumor with hyperpigmentation: association with a germline mutation of the c-kit gene

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

7 January 2021

Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT)

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

7 January 2021

Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

7 January 2021

Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

7 January 2021

c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant

1 reference

https://api.crossref.org/works/10.1038/LABINVEST.3700122

7 January 2021